29
Nanomedicines

Nanomedicines. Nanomedicines for diagnosis and therapy

Embed Size (px)

Citation preview

Page 1: Nanomedicines. Nanomedicines for diagnosis and therapy

Nanomedicines

Page 2: Nanomedicines. Nanomedicines for diagnosis and therapy

Nanomedicines for diagnosis and therapy

Page 3: Nanomedicines. Nanomedicines for diagnosis and therapy

Materials for nano-medicines

Page 4: Nanomedicines. Nanomedicines for diagnosis and therapy

Importance of nanomedicine for cancer treatments

RES: An older term for the mononuclear phagocyte system

- A part of the immune system that consists of the phagocytic cells located in reticular connective tissue. - The cells are primarily monocytes and macrophages, and they accumulate in lymph nodes and the spleen.

Page 5: Nanomedicines. Nanomedicines for diagnosis and therapy

Nano-carriers for drug delivery

Page 6: Nanomedicines. Nanomedicines for diagnosis and therapy
Page 7: Nanomedicines. Nanomedicines for diagnosis and therapy

Liposomes

Page 8: Nanomedicines. Nanomedicines for diagnosis and therapy

Advantages of liposome structure

Page 9: Nanomedicines. Nanomedicines for diagnosis and therapy
Page 10: Nanomedicines. Nanomedicines for diagnosis and therapy

Polysomes

Page 11: Nanomedicines. Nanomedicines for diagnosis and therapy

Polymeric micells

Page 12: Nanomedicines. Nanomedicines for diagnosis and therapy

Amphiphilic polymers for micells

Page 13: Nanomedicines. Nanomedicines for diagnosis and therapy

Advantage of polymeric micells

Page 14: Nanomedicines. Nanomedicines for diagnosis and therapy

Drug release from polymeric micells

Page 15: Nanomedicines. Nanomedicines for diagnosis and therapy

Other types of polymeric micells

Page 16: Nanomedicines. Nanomedicines for diagnosis and therapy

Dendrimers

Page 17: Nanomedicines. Nanomedicines for diagnosis and therapy

Advantages of dendrimers

Page 18: Nanomedicines. Nanomedicines for diagnosis and therapy

Hydrogel nanoparticles

Page 19: Nanomedicines. Nanomedicines for diagnosis and therapy

Stealth effect of PEGs

Page 20: Nanomedicines. Nanomedicines for diagnosis and therapy

Doxorubicine-EG-Folate modified micells

Page 21: Nanomedicines. Nanomedicines for diagnosis and therapy

Doxorubicin

Page 22: Nanomedicines. Nanomedicines for diagnosis and therapy

Liposome products

Page 23: Nanomedicines. Nanomedicines for diagnosis and therapy

Angiogenesis in cancers

Page 24: Nanomedicines. Nanomedicines for diagnosis and therapy

ERP (Enhanced permeability and retention) effect

Page 25: Nanomedicines. Nanomedicines for diagnosis and therapy

Leaky blood vessels in tumors

Page 26: Nanomedicines. Nanomedicines for diagnosis and therapy

Passive tumor targeting by EPR effect

Page 27: Nanomedicines. Nanomedicines for diagnosis and therapy

Tumor targeting in nano-medicines

Page 28: Nanomedicines. Nanomedicines for diagnosis and therapy

Barriers in in-vivo implementation

Page 29: Nanomedicines. Nanomedicines for diagnosis and therapy

Lipid emulsion